Svai S Sanford is Chief Financial Officer of Rani Therapeutics Holdings, Inc.. Currently has a direct ownership of 258,597 shares of RANI, which is worth approximately $558,569. The most recent transaction as insider was on Mar 27, 2023, when has been sold 139,000 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 259K
0% 3M change
0% 12M change
Total Value Held $558,569

Svai S Sanford Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 27 2023
BUY
Grant, award, or other acquisition
-
139,000 Added 34.96%
258,597 Class A Common Stock
Mar 22 2023
SELL
Payment of exercise price or tax liability
$19,962 $5.95 p/Share
3,355 Reduced 2.73%
119,597 Class A Common Stock
Sep 09 2022
SELL
Payment of exercise price or tax liability
$181,600 $9.89 p/Share
18,362 Reduced 13.2%
120,738 Class A Common Stock
Mar 22 2022
BUY
Grant, award, or other acquisition
-
32,900 Added 19.13%
139,100 Class A Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
-
106,200 Added 50.0%
106,200 Class A Common Stock
SSS

Svai S Sanford

Chief Financial Officer
San Jose, CA

Track Institutional and Insider Activities on RANI

Follow Rani Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RANI shares.

Notify only if

Insider Trading

Get notified when an Rani Therapeutics Holdings, Inc. insider buys or sells RANI shares.

Notify only if

News

Receive news related to Rani Therapeutics Holdings, Inc.

Track Activities on RANI